JP2025501865A5 - - Google Patents
Info
- Publication number
- JP2025501865A5 JP2025501865A5 JP2024532504A JP2024532504A JP2025501865A5 JP 2025501865 A5 JP2025501865 A5 JP 2025501865A5 JP 2024532504 A JP2024532504 A JP 2024532504A JP 2024532504 A JP2024532504 A JP 2024532504A JP 2025501865 A5 JP2025501865 A5 JP 2025501865A5
- Authority
- JP
- Japan
- Prior art keywords
- agent according
- light antibody
- light
- administered
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263296786P | 2022-01-05 | 2022-01-05 | |
| US63/296,786 | 2022-01-05 | ||
| US202263396308P | 2022-08-09 | 2022-08-09 | |
| US63/396,308 | 2022-08-09 | ||
| PCT/US2023/060064 WO2023133389A2 (en) | 2022-01-05 | 2023-01-04 | Methods of treating asthma with anti-light antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501865A JP2025501865A (ja) | 2025-01-24 |
| JP2025501865A5 true JP2025501865A5 (enExample) | 2026-01-15 |
Family
ID=87074254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024532504A Pending JP2025501865A (ja) | 2022-01-05 | 2023-01-04 | 抗ｌｉｇｈｔ抗体で喘息を治療する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250002598A1 (enExample) |
| EP (1) | EP4460523A4 (enExample) |
| JP (1) | JP2025501865A (enExample) |
| AU (1) | AU2023205910A1 (enExample) |
| CA (1) | CA3240327A1 (enExample) |
| WO (1) | WO2023133389A2 (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2484696B1 (en) * | 2006-08-28 | 2017-08-16 | Kyowa Hakko Kirin Co., Ltd. | Antagonistic hLIGHT-specific human monoclonal antibodies |
| EP3750554A3 (en) * | 2007-09-18 | 2021-07-28 | La Jolla Institute for Allergy and Immunology | Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment |
| HK1257443A1 (zh) * | 2015-08-21 | 2019-10-18 | The Children's Hospital Of Philadelphia | 治疗具有dcr3或dcr3网络基因中的遗传变异的患者的自身免疫病症的方法 |
-
2023
- 2023-01-04 AU AU2023205910A patent/AU2023205910A1/en active Pending
- 2023-01-04 WO PCT/US2023/060064 patent/WO2023133389A2/en not_active Ceased
- 2023-01-04 JP JP2024532504A patent/JP2025501865A/ja active Pending
- 2023-01-04 CA CA3240327A patent/CA3240327A1/en active Pending
- 2023-01-04 EP EP23737702.3A patent/EP4460523A4/en active Pending
-
2024
- 2024-06-27 US US18/756,623 patent/US20250002598A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025038127A5 (enExample) | ||
| JP2022120009A (ja) | ベンラリツマブを使用して喘息の増悪率を低減する方法 | |
| EP3076972B1 (en) | Cancer treatment with combination of plinabulin and taxane | |
| RU2015109716A (ru) | Способы лечения или предотвращения астмы посредством введения антагониста il-4r | |
| JP2020516647A5 (enExample) | ||
| JP2024129140A5 (enExample) | ||
| RU2703568C2 (ru) | Способы повышения форсированного объема выдоха у больных астмой с применением бенрализумаба | |
| JP2022530533A (ja) | Ｉｌ－３３アンタゴニストを投与することにより喘息を治療するまたは予防するための方法 | |
| JP2020100653A (ja) | ベンラリツマブによる喘息症状の改善方法 | |
| RU2706729C2 (ru) | Способы лечения хронической обструктивной болезни легких с использованием бенрализумаба | |
| CA2962944A1 (en) | Use of reslizumab to treat moderate to severe eosinophilic asthma | |
| JP2023505215A5 (enExample) | ||
| SHAHIDI et al. | Pulse versus oral methylprednisolone therapy in pemphigus vulgaris | |
| JP2025106329A (ja) | ベンラリズマブを使用した強化された患者個体群における慢性閉塞性肺疾患を治療するための方法 | |
| Obase et al. | Efficacy and safety of long-term treatment of asthmatic patients with pranlukast, a cysteinyl-leukotriene-receptor antagonist: four-year followup study | |
| RU2025128783A (ru) | Способы лечения хронической обструктивной болезни легких (copd) путем введения антагониста il-4r | |
| Che et al. | Attrition in the treatment cascade among elderly patients with multidrug-resistant TB. | |
| RU2023120407A (ru) | Способы лечения или предотвращения астмы посредством введения антагониста il-4r | |
| Piña et al. | Etanercept as a possible trigger of fatal pulmonary fibrosis | |
| zaheer Ahmed | Myasthenia Gravis: Past, Present and Future | |
| HK1240824A1 (en) | Use of reslizumab to treat moderate to severe eosinophilic asthma | |
| HK1224583A1 (en) | Methods for treating chronic obstructive pulmonary disease using benralizumab |